CMOPF (Cosmo NV) Research & Development: $39.7 Mil (TTM As of Dec. 2025)


CMOPF Cosmo NV CMOPF
82 GF Score
Price $82.14
GF Value $54.86
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cosmo NV Research & Development?

Cosmo NV CMOPF +0.80% 82 Research & Development is $39.7 Mil as of Dec. 2025. GuruFocus rates CMOPF with a GF Score™ of 82/100 and a GF Value™ of $54.86 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cosmo NV's Research & Development for the six months ended in Dec. 2025 was $18.9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $39.7 Mil.

Cosmo NV  (OTCPK:CMOPF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cosmo NV Research & Development Related Terms

Cosmo NV Research & Development Historical Data

* Premium members only.

The historical data trend for Cosmo NV's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo NV Research & Development Chart

Cosmo NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 3.45 41.81 40.02

Cosmo NV Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.59 20.60 21.77 20.76 18.94
CMOPF
82GF Score
Cosmo NV CMOPF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cosmo NV Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $39.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $39.7 Mil mean?
Cosmo NV (CMOPF) has a Research & Development of $39.7 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Cosmo NV and its competitors.
Is Cosmo NV's Research & Development too high?
Cosmo NV's current Research & Development is $39.7 Mil. Overall, Cosmo NV has a GF Score™ of 82/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cosmo NV's Research & Development compare to LLY and JNJ?
Cosmo NV's Research & Development of $39.7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cosmo NV and its competitors. Cosmo NV's current Research & Development is $39.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmo NV stock overvalued right now?
Based on GuruFocus' analysis, Cosmo NV (CMOPF) is currently considered Significantly Overvalued. The stock's GF Value™ is $54.86, compared to a current price of $82.14 — trading 49.7% above its estimated fair value. The current Research & Development is $39.7 Mil. Cosmo NV's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cosmo NV (CMOPF), the current Research & Development is $39.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmo NV (CMOPF) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo NV stock appears to be overvalued. The current stock price of $82.14 is trading 49.7% above its estimated GF Value™ of $54.86. GuruFocus considers Cosmo NV to be Significantly Overvalued.

Key valuation signals for CMOPF:

  • Research & Development: $39.7 Mil
  • GF Value™: $54.86 vs. price of $82.14 (49.7% above fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the CMOPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmo NV Business Description

Address 91/94 North Wall Quay, 7th Floor, One North Dock, Dublin, IRL, D01 H7V7
Cosmo NV is is a life sciences company. The company is focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). The company designs, develops, and manufactures solutions to address critical medical needs. Its technologies are trusted by international pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. The product pipeline includes Eleview, GI Genius, Winlevi, Lialda, Uceris, and others.
82GF Score

Get the complete analysis for CMOPF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$82.14
Price
$54.86
GF Value